Navigation Links
ERT Announces Clearance from German Federal Cartel Office
Date:6/6/2012

py of the proxy statement and other relevant documents filed with the SEC from the SEC's website at www.sec.gov. ERT's stockholders will also be able to obtain, without charge, a copy of the proxy statement and other relevant documents (when available) by going to the Investors section of ERT's corporate website, www.ERT.com, or directing a request by mail or telephone to ERT, 1818 Market Street, Philadelphia, PA 19103-3638 – Attention Investor Relations.

ERT and its directors and officers may be deemed to be participants in the solicitation of proxies from ERT's stockholders with respect to the special meeting of stockholders that will be held to consider the merger. Information about ERT's directors and executive officers and their ownership of ERT's common stock is set forth in the definitive proxy statement. Stockholders may obtain additional information regarding the interests of ERT and its directors and executive officers in the merger, which may be different than those of the company's stockholders generally, by reading the definitive proxy statement and other relevant documents regarding the merger.

­­ERT Contact:
Keith Schneck
ERT
215-282-5566

Genstar Contact:
Chris Tofalli
Chris Tofalli Public Relations
914-834-4334


'/>"/>
SOURCE eResearchTechnology, Inc. (ERT)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
2. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
3. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
4. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
5. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
6. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
7. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
8. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
9. Regeneron Announces June 2012 Investor Conference Presentations
10. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
11. Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Transparency Market Research has published ... Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, ... Volume, Share, Growth, Trends and Forecast 2014 - 2022 ... published by Transparency Market Research " Non-invasive Prenatal Testing ... Trends and Forecast 2014 - 2022 ", the global ...
(Date:8/4/2015)... , Aug. 4, 2015 BioElectronics ... over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced ... of its ActiPatch 7-day trial device has been ... Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More ... survey and submitted an assessment.  ...
(Date:8/4/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/nl392k/alcohol ) has announced ... Application (Household & Personal Care, Pharmaceutical, Oilfield, Agrochemicals, and ... report to their offering. The ... million in 2014 and is projected to grow at ... The data mentioned in the report is based on ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3
... Compare Genous vs. Drug-Eluting and Bare ... ... in the,randomized TRIAS (TRI-stent Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R ... April, according to Robbert de Winter, M.D., Ph.D.,principal investigator and director ...
... 16 Protocol Driven Healthcare,Inc. (PDHI) today ... Hallmark Insights to provide fully integrated incentive ... ConXus health improvement platform. ConXus Rewards ... points earned by participants completing activities within ...
Cached Medicine Technology:Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
(Date:8/4/2015)... ... August 04, 2015 , ... Bayco Products, Inc. announces a new industrial-grade ... example, on hard hats that have a flip-up face shield. The sleek contours of ... work without having to remove their headlamp when raising or lowering their face shield ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... United States, Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective ... will save lives," Dr. Carmona said. "I strongly believe in the mission of ...
(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s 4th Annual ... 3 – 4, 2015, at UC San Diego, will explore innovations that farmers ... access, and manage resources efficiently against the dueling backdrop of a lingering Western ...
(Date:8/4/2015)... ... August 04, 2015 , ... Many men are confused about the safety of ... standing up as a voice of authority for men seeking accurate information about testosterone. ... special experience and expertise in the safe and effective treatment of low testosterone. In ...
(Date:8/4/2015)... ... 04, 2015 , ... They say a picture is worth a thousand words, ... medical art can be essential. StayWell, a health solutions company, announced today it will ... have been used by physicians and other health care providers for more than 40 ...
Breaking Medicine News(10 mins):Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3
... lab and mice studies, compound halts disease without crimping ... A compound derived from hydrangea root, an herb used ... autoimmune disorder in laboratory mice and human cells, new ... promising, the researchers said, is that it slowed progression ...
... www.remudaranch.com ) Reports Many Patients with Eating Disorders Exhibit Weight ... /PRNewswire/ -- Everyone checks their body ... check their body and often in a way that,s unusual. ... , "Sometimes body and weight checking becomes second nature and ...
... CAMBRIDGE, Mass., June 4 Prize4life and the Alzheimer Research Forum ... . ResearchALS.or g ), a web-based resource for ... Gehrig,s disease or motor neuron disease. The site is modeled ... is the first step in Prize4Life,s efforts to build a similar ...
... (Nasdaq: AIRM ), the largest air medical transportation ... Francis Health System and St. John Health System in Tulsa, ... air medical program. This represents the first expansion of Air ... , Effective June 1, 2009, Tulsa Life Flight expanded ...
... LOHAS unites Fortune 500 leaders with emerging entrepreneurs and ... Lifestyles of Health and Sustainability (LOHAS) ... debut of the LOHAS Venture Capital Fair. Through ... facilitates financing of next generation organic and health and ...
... , ... magazine to focus on current on-going research in Asia has been launched by ResearchSEA. , ... (PRWeb UK) June 4, 2009 -- Asia ... been launched by ResearchSEA . Asia is an exciting place for research right now and ...
Cached Medicine News:Health News:Herb May Offer Hope for Autoimmune Diseases 2Health News:Herb May Offer Hope for Autoimmune Diseases 3Health News:Body and Weight Checking May Signify an Eating Disorder 2Health News:Body and Weight Checking May Signify an Eating Disorder 3Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 2Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 3Health News:Air Methods Expands Community-Based Operations Into Eastern Oklahoma 2Health News:LOHAS Announces Final Program Line-up Including Speakers from Wal-Mart, Coca Cola, MINI, Facebook Causes, Saatchi & SaatchiS, Gaiam and eBay 2Health News:Launch of Asia Research News 2009 2Health News:Launch of Asia Research News 2009 3
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
12% Tryptone, 24% Yeast Extract, 4.0% Glycerol. Supplied with 1 liter of 10x phosphate buffer (0190-1L)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
Medicine Products: